Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.53 USD | -1.58% | +10.28% | -4.05% |
08/05 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
08/05 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.05% | 297.48Cr | |
+7.90% | 11TCr | |
+10.34% | 11TCr | |
+0.41% | 2.23TCr | |
-11.88% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.92% | 1.72TCr | |
+7.05% | 1.43TCr | |
+36.43% | 1.25TCr |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Wedbush Trims Denali Therapeutics' Price Target to $37 From $38, Notes Slightly Higher Share Count; Keeps Outperform Rating